Germany

Healthcare Market Update | Q3 2024

Latest market trends, valuation levels, and deals

M&A activities are driven by stable demand, innovation, and macroeconomic challenges for SMEs.

We are pleased to present the latest edition of our Healthcare Sector Market Update for the third quarter of 2024. In this edition, we provide an update on the latest industry trends, insights into current valuation levels, and recent transactions.

Interest rate cuts by international central banks, innovative products such as GLP-1 receptor agonists (e.g., Ozempic), as well as macroeconomic challenges like persistent inflation, high energy costs, and supply chain disruptions are key drivers of M&A activity across Europe.

We hope you enjoy reading the report and look forward to exchanging ideas with you soon.

Healthcare Market Update Q3 2024.pdf Download PDF

Your Healthcare team at Oaklins Germany

Christian Jellentrup Hamburg, Germany
Director
View profile

Florian Engel Hamburg, Germany
Senior Associate
View profile

Christian Ernst Hamburg, Germany
Senior Associate
View profile

Stephan Gröger Hamburg, Germany
Associate
View profile

Related Healthcare articles

9 October 2024 Strategic moves and sector-specific trends

QUARTERLY M&A ACTIVITY: From securing growth capital to finding future partners, Oaklins' Q3 deals reflect strategic navigation in dynamic industry...

1 October 2024 Acquisition of AMC Media sets the stage for Formedics’ next chapter

DEAL FLASH: AMC Media Group, a healthcare professional (HCP) community platform that enables medical associations and key opinion leaders (KOLs) to...

30 July 2024 Oaklins Germany M&A Market Report 1st Half of 2024

Surprisingly stable M&A activity in Germany in the first half of 2024: Despite economic challenges, geopolitical crises, and an increase in corpora...